ENEmsehgol Nikmahzar

Emsehgol Nikmahzar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Emsehgol Nikmahzar has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pomegranate Seed Oil Boosts Memory by Reducing Amyloid Plaques and Restoring Neuronal Density in Alzheimer’s Model Rats

    by Mehrdad Jahanshahi, Vahid Khori, Emsehgol Nikmahzar, Fateme Yazdani, Elsana Jahanshahi, Gozal Bahlakeh

    Background: Pomegranate seed oil possesses antioxidant, anti-inflammatory, and neuroprotective properties. Alzheimer's disease is a prevalent neurodegenerative disorder that results in behavioral and cognitive impairments. Objectives: This study aimed to investigate the effects of pomegranate seed oil on memory impairment, neuronal density, and amyloid beta (Aβ) plaque in the hippocampus of rats, both pre- and post-scopolamine administration. Methods: Fifty-six male Wistar rats were randomly assigned to seven groups. Rats received intraperitoneal injections of pomegranate seed oil (0.32 and 0.64 mg/kg) or saline for 14 days, either before or after intraperitoneal infusion of scopolamine (3 mg/kg). Memory function was assessed using the passive avoidance test. Cresyl violet and Congo red staining techniques were employed to evaluate hippocampal neuronal density and Aβ plaques, respectively. Results: Evaluation of memory using the passive avoidance test after scopolamine injection revealed a significant reduction in memory retention. Treatment with pomegranate seed oil at a dose of 0.32 mg/kg improved memory performance both before and after scopolamine injection; however, this improvement was not statistically significant. Scopolamine significantly increased the number of amyloid plaques (P < 0.0001) and significantly decreased the number of neurons in the hippocampus (P < 0.0001) compared to control rats. Pomegranate seed oil at doses of 0.32 and 0.64 mg/kg significantly reduced the density of amyloid plaques (P < 0.0001) and increased the number of neurons in the hippocampus when compared to saline-treated rats. Conclusions: Pomegranate seed oil demonstrated significant neuroprotective and therapeutic effects by enhancing neuronal density and reducing amyloid plaque formation in the hippocampus. Therefore, pomegranate seed oil is suggested as a potential treatment for alleviating symptoms associated with Alzheimer’s disease.


  • Open Access

    L-α-aminoadipic Acid-induced Astrocytes Inhibition in the Hippocampal CA1 Region, Anxiety-like Behavior, and Memory Impairment

    by Mehrdad Jahanshahi, Leila Elyasi, Emsehgol Nikmahzar

    Introduction: Glutamate plays a significant role in synaptic plasticity, which is important for learning and memory. Astrocytes are an important part of glial cells or neuroglia. They are involved in neuroinflammation and are key in maintaining glutamine/glutamate homeostasis. As astrocytes provide vital support to neurons in pathological conditions, we aimed to ...

  • Apelin–13 protects against memory impairment and neuronal loss, Induced by Scopolamine in male rats

    by Sara Gazmeh, Maryam Azhir, Leila Elyasi, Mehrdad Jahanshahi, Emsehgol Nikmahzar, Seyed Behnamedin Jameie

    The present study aimed to evaluate the effects of Apelin–13 on scopolamine–induced memory impairment in rats. Forty male rats were divided into five groups of eight. The control group received no intervention; the scopolamine group underwent stereotaxic surgery and received 3 mg/kg intraperitoneal scopolamine. The treatment groups additionally received 1.25, 2.5 and 5 µg apelin–13 in right lateral ventricles for 7 days. All rats (except the control group) were tested for the passive avoidance reaction, 24 h after the last drug injection. For histological analysis, hippocampal sections were stained with cresyl violet; synaptogenesis biochemical markers were determined by immunoblotting. Apelin–13 alleviated scopolamine–induced passive avoidance memory impairment and neuronal loss in the rats’ hippocampus (P<0.001). The reduction observed in mean concentrations of hippocampal synaptic proteins (including neurexin1, neuroligin, and postsynaptic density protein 95) in scopolamine–treated animals was attenuated by apelin–13 treatment. The results demonstrated that apelin–13 can protect against passive avoidance memory deficiency, and neuronal loss, induced by scopolamine in male rats. Further experimental and clinical studies are required to confirm its therapeutic potential in neurodegenerative diseases.


  • The effect of vitamin B12 on synaptic plasticity of hippocampus in Alzheimer’s disease model rats

    by Jahanshahi Mehrdad, Elyasi Leila, Nikmahzar Emsehgol

    Hippocampus cells, responsible for learning and memory, are disturbed in Alzheimer’s disease (AD), resulting in production of several inflammatory markers, such as neurexin 1 –neuroligin, cyclooxyg...


  • Open Access

    Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer's disease

    by Mehrdad Jahanshahi, Emsehgol Nikmahzar, Ali Sayyahi

    Vitamin E may have beneficial effects on oxidative stress and Aβ-associated reactive oxygen species production in Alzheimer’s disease. But, the exact role of vitamin E as a treatment for Alzheimer’s disease pathogenesis still needs to be studied. Hence, we examined the therapeutic effects of vitamin E on the density of congophilic amyloid plaques and neurofibrillary tangles in rats’ hippocampi. Wistar rats were randomly assigned to control (no drug treatment), sham scopolamine (3 mg/kg)+saline and Sham scopolamine+sesame oil groups, and three experimental groups that received scopolamine+vitamin E (25, 50, and 100 mg/kg/day) daily for 14 days after scopolamine injection. The rats’ brains were collected immediately following transcardial perfusion and fixed in 4% paraformaldehyde. Pathological brain alterations were monitored through Congo red and bielschowsky silver staining. Scopolamine treatment led to a significant increase in the density of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus. IP injection of vitamin E in three doses (25, 50, and 100 mg/kg/day) significantly reversed the scopolamine-induced increase of the congophilic amyloid plaque density and density of neurofibrillary tangles in the hippocampus. Although vitamin E (25 and 50 mg/kg/day) doses were also effective, but a 100 mg/kg/day dose of vitamin E was more effective in the reduction of congophilic amyloid plaque and neurofibrillary tangle density. Vitamin E could exert a therapeutic effect in the reduction of congophilic amyloid plaque and neurofibrillary tangle density in the hippocampus of scopolamine-treated rats and it is useful for Alzheimer’s disease.


  • Open Access

    Human chorionic gonadotropin attenuates amyloid-β plaques induced by streptozotocin in the rat brain by affecting cytochrome c-ir neuron density

    by Emsehgol Nikmahzar, Mehrdad Jahanshahi, Leila Elyasi, Mohsen Saeidi, Fatemeh Babakordi, Gozal Bahlakeh

    Objective(s): Amyloid beta plaques, in Alzheimer's disease, are deposits in different areas of the brain such as prefrontal cortex, molecular layer of the cerebellum, and the hippocampal formation. Amyloid beta aggregates lead to the release of cytochrome c and finally neuronal cell death in brain tissue. hCG has critical roles in brain development, neuron differentiation, and function. Therefore, we investigated the effect of hCG on the density of the congophilic A beta plaque and cytochrome c-ir neurons in the hippocampus, prefrontal cortex, and cerebellum of Streptozotocin (STZ)-treated rats. Materials and Methods: Alzheimer model in rats (except the control group) was induced by streptozotocin (3 mg/kg, Intracerebroventricularly (ICV)). Experimental group rats received streptozotocin and then different doses of hCG (50, 100, and 200 IU, intraperitoneally) for 3 days. 48 hr after last drug injection and after histological processing, the brain sections were stained by congo red for congophilic amyloid beta plaques and cytochrome c in the hippocampus, prefrontal cortex, and cerebellum were immunohistochemically stained. Results: Density of congophilic A beta plaques and cytochrome c-immunoreactive neurons was significantly higher in ICV STZ treated rats than controls. Treatment with three doses of hCG significantly decreased the density of congophilic A beta plaques and cytochrome c-immunoreactive neurons in the rat hippocampus, prefrontal cortex, and cerebellum in ICV STZ-treated rats (P<0.05). Conclusion: : hCG can be useful in AD patients to prevent the congophilic A beta plaque formation and decrease cytochrome c-immunoreactive neuron density in the brain.


  • Open Access

    Ginkgo biloba Extract Decreases Scopolamine-Induced Congophilic Amyloid Plaques Accumulation in Male Rat's Brain

    by Emsehgol Nikmahzar, Mehrdad Jahanshahi, Fatemeh Babakordi

    Jundishapur Journal of Natural Pharmaceutical Products


  • Open Access

    The Protective Effects of Citrus aurantium Flower Extract against 6-Hydroxydopamine-Mediated Cell Damage in Human Neuroblastoma SH-SY5Y Cells

    by Leila Elyasi, Mehrdad Jahanshahi, Hamed Ghazvini, Emsehgol Nikmahzar

    Parkinson’s disease (PD) is described as a neurological condition, resulting from continuous degeneration of dopaminergic neurons. Currently, most treatments for neurodegenerative diseases are palliative. In traditional Iranian medicine, Citrus aurantium flower extract is used to treat some neural diseases, such as sleep disorders and anxiety. The tendency towards the use of medicinal herbs for the treatment of diseases (eg, seizure) is growing. Accordingly, we evaluated the antioxidant effects of C. aurantium flowers and analyzed their protective effects against 6-hydroxydopamine (6-OHDA)-mediated oxidative stress. In this study, 150 mM of 6-OHDA was used to induce cellular damage. Also, MTT assay was performed to analyze cellular viability. Fluorescence spectrophotometry was performed to measure the intracellular reactive oxygen species (ROS) and calcium levels. Based on the findings, 6-OHDA could reduce cell viability. We also analyzed the effects of C. aurantium against neurotoxicity. The intracellular levels of ROS and calcium greatly improved in cells exposed to 6-OHDA. SH-SY5Y cell incubation with C. aurantium (400 and 600 mg/mL) induced protective effects and decreased the biochemical markers of cell apoptosis. According to the findings, C. aurantium showed protective effects against neurotoxicity, caused by 6-OHDA; these protective properties were accompanied by antiapoptotic features. According to the findings, it seems that hydromethanolic C. aurantium extract can be used to prevent seizures.


  • α2-Adrenoceptor-ir neurons’ density changes after single dose of clonidine and yohimbine administration in the hippocampus of male rat

    by M. Jahanshahi, E. Nikmahzar, L. Elyasi, F. Babakordi, E. Hooshmand

    Objective: Despite the important role of α2-adrenoceptors in pain modulation processes, the impact of administration of α2-adrenoceptor agonist and antagonist on the density of hippocampal α2-adrenoceptor-immunoreactive neurons has not been investigated. Therefore, we aimed to determine the effect of single doses of clonidine and yohimbine on the density of α2-adrenoceptor-immunoreactive neurons in rat hippocampus. Materials and Methods: Adult male Wistar rats received a single dose of clonidine (0.7 mg/kg) alone or 5 min after intraperitoneal (1 mg/kg) and/or intracerebroventricular (5 µg/kg) injection of yohimbine. After histological processing, neurons with α2-adrenoceptor immunoreactivity were identified and counted through immunohistochemical analysis of hippocampal regions. Results: Clonidine slightly increased the number of α2-adrenoceptor-immunoreactive neurons in the hippocampal subregions compared with the normal saline group. Intraperitoneal injection of yohimbine followed by injection of clonidine significantly increased the number of α2-adrenoceptor-immunoreactive neurons in subregions cornu ammonis 1 (CA1) and cornu ammonis 3 (CA3). Intracerebroventricular injection of yohimbine after injection of clonidine significantly reduced the number of α2-adrenoceptor-immunoreactive neurons in all hippocampal subregions. Conclusion: The present study demonstrates that intraperitoneal administration of α2-adrenoceptor agonist clonidine increases the density of α2-adrenoceptor-immunoreactive neurons in rat hippocampus, while intracerebroventricular injection of yohimbine decreases the density of these neurons.


  • Open Access

    Hippocampal serotonin-2A receptor-immunoreactive neurons density increases after testosterone therapy in the gonadectomized male mice

    by Emsehgol Nikmahzar, Mehrdad Jahanshahi, Amir Ghaemi, Gholam Reza Naseri, Ali Reza Moharreri, Ahmad Ali Lotfinia

    Nikmahzar E, et al. Anat Cell Biol. 2016 Dec;49(4):259-272. https://doi.org/10.5115/acb.2016.49.4.259